SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-271925
Filing Date
2023-11-07
Accepted
2023-11-07 07:40:33
Documents
15
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d893832d8k.htm   iXBRL 8-K 29161
2 EX-99.1 d893832dex991.htm EX-99.1 109458
7 GRAPHIC g893832g1107032211543.jpg GRAPHIC 7282
  Complete submission text file 0001193125-23-271925.txt   325292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20231107.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20231107_def.xml EX-101.DEF 14109
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20231107_lab.xml EX-101.LAB 23493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20231107_pre.xml EX-101.PRE 15142
9 EXTRACTED XBRL INSTANCE DOCUMENT d893832d8k_htm.xml XML 6649
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 231381606
SIC: 2834 Pharmaceutical Preparations